
Gufic BioSciences Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment
2026-02-03 11:05:28Gufic BioSciences Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 6.44% higher than its previous close, signalling a strong start amid positive market sentiment in the Pharmaceuticals & Biotechnology sector.
Read full news article
Gufic BioSciences Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend
2026-02-02 16:01:22Gufic BioSciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recently touched a 52-week low, closing just 2.83% above its lowest price of Rs 285. The stock’s recent performance reflects a sustained downward trajectory, with notable underperformance relative to its sector and broader market indices.
Read full news article
Gufic BioSciences Ltd is Rated Strong Sell
2026-02-01 10:10:56Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 01 February 2026, providing investors with the latest view on the company’s position.
Read full news article
Gufic BioSciences Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend
2026-01-28 16:01:22Shares of Gufic BioSciences Ltd have declined to within 4.84% of their 52-week low, marking a significant downturn for the pharmaceutical and biotechnology company. The stock closed near Rs 285, reflecting a sustained period of depreciation amid broader market gains.
Read full news article
Gufic BioSciences Ltd is Rated Strong Sell
2026-01-21 10:10:53Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 21 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Gufic BioSciences Ltd is Rated Strong Sell
2026-01-10 10:10:49Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Gufic BioSciences Ltd Faces Intensified Downtrend Amid Technical Weakness
2026-01-09 08:02:11Gufic BioSciences Ltd has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend across multiple timeframes. The company’s shares have declined by 2.88% today, reflecting growing investor caution amid deteriorating technical signals and a downgrade in its Mojo Grade to Strong Sell.
Read full news article
Gufic BioSciences Ltd Faces Bearish Momentum Amid Technical Indicator Shifts
2026-01-05 08:02:04Gufic BioSciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its technical momentum, with several indicators signalling a bearish trend. Despite a modest weekly price gain, the stock’s overall technical profile has deteriorated, prompting a downgrade to a Strong Sell rating by MarketsMOJO as of 17 Nov 2025.
Read full news article
Gufic BioSciences Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-01-01 08:01:45Gufic BioSciences Ltd has experienced a notable shift in its technical momentum, reflecting a complex interplay of mildly bearish and bullish signals across key indicators. Despite a modest daily price increase of 0.93%, the stock remains under pressure with a Strong Sell mojo grade, underscoring ongoing challenges in the Pharmaceuticals & Biotechnology sector.
Read full news articleIntimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
20-Jan-2026 | Source : BSEIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is attached herewith
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Jan-2026 | Source : BSECertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025 is attached herewith
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
27-Dec-2025 | Source : BSEIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is attached herewith.
Corporate Actions
No Upcoming Board Meetings
Gufic BioSciences Ltd has declared 10% dividend, ex-date: 22 Sep 25
No Splits history available
No Bonus history available
No Rights history available






